Business & Economy

Will coronavirus help ‘greedy’ pharma reset reputation?

As drug companies around the world work at breakneck speed to develop coronavirus vaccines and treatments, there are expectations that the industry, often accused of being brazenly profit-centric, could redeem its reputation by not engaging in price gauging or profiteering and ensuring the eventual vaccines and treatments are widely available, even in poorer countries.          More than 120 vaccines are under development and […]